Zhuhai Sailong Pharmaceutical Co Ltd (002898) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.062x

Based on the latest financial reports, Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a cash flow conversion efficiency ratio of -0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-28.66 Million ≈ $-4.19 Million USD) by net assets (CN¥460.47 Million ≈ $67.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhuhai Sailong Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Zhuhai Sailong Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhuhai Sailong Pharmaceutical Co Ltd (002898) total liabilities for a breakdown of total debt and financial obligations.

Zhuhai Sailong Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhuhai Sailong Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hanyang Digitech Co. Ltd KQ:078350	0.008x
Aspo Oyj HE:ASPO	0.157x
Guangdong Electric Power Devel SHE:200539	0.066x
Alta Equipment Group Inc NYSE:ALTG	0.862x
ASIX Electronics TWO:3169	0.054x
Filatex India Limited NSE:FILATEX	0.166x
Azkoyen MC:AZK	0.141x
Sukgyung AT Co. Ltd. KQ:357550	0.047x

Annual Cash Flow Conversion Efficiency for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see 002898 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥499.28 Million ≈ $73.06 Million	CN¥-38.86 Million ≈ $-5.69 Million	-0.078x	-216.81%
2023-12-31	CN¥535.88 Million ≈ $78.42 Million	CN¥35.71 Million ≈ $5.23 Million	0.067x	+148.30%
2022-12-31	CN¥526.35 Million ≈ $77.02 Million	CN¥14.12 Million ≈ $2.07 Million	0.027x	-57.35%
2021-12-31	CN¥563.66 Million ≈ $82.48 Million	CN¥35.46 Million ≈ $5.19 Million	0.063x	+21040.16%
2020-12-31	CN¥587.00 Million ≈ $85.90 Million	CN¥174.69K ≈ $25.56K	0.000x	+100.42%
2019-12-31	CN¥659.02 Million ≈ $96.44 Million	CN¥-46.52 Million ≈ $-6.81 Million	-0.071x	-1507.08%
2018-12-31	CN¥663.54 Million ≈ $97.10 Million	CN¥3.33 Million ≈ $487.06K	0.005x	-96.35%
2017-12-31	CN¥618.64 Million ≈ $90.53 Million	CN¥85.13 Million ≈ $12.46 Million	0.138x	-55.48%
2016-12-31	CN¥254.45 Million ≈ $37.23 Million	CN¥78.65 Million ≈ $11.51 Million	0.309x	+38.92%
2015-12-31	CN¥213.20 Million ≈ $31.20 Million	CN¥47.44 Million ≈ $6.94 Million	0.223x	-39.11%
2014-12-31	CN¥140.55 Million ≈ $20.57 Million	CN¥51.36 Million ≈ $7.52 Million	0.365x	-36.90%
2013-12-31	CN¥111.97 Million ≈ $16.38 Million	CN¥64.84 Million ≈ $9.49 Million	0.579x	--

About Zhuhai Sailong Pharmaceutical Co Ltd

SHE:002898 China Biotechnology

Market Cap

$213.76 Million

CN¥1.46 Billion CNY

Market Cap Rank

#16296 Global

#4650 in China

Share Price

CN¥8.30

Change (1 day)

-5.03%

52-Week Range

CN¥6.57 - CN¥16.81

All Time High

CN¥29.47